Is VBIO or DIVO a better dividend investment in 2026?

VBIO currently yields 512.82% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: VBIO offers higher current income.

What is the dividend yield difference between VBIO and DIVO?

VBIO has a forward dividend yield of 512.82% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 506.33 percentage points.

Home › Compare › VBIO vs DIVO

VBIO vs DIVO: Dividend Comparison 2026

VBIO yields 512.82% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VBIO wins by $74719.34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VBIO

● Live price

512.82%

Share price

$0.39

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$74719.37M

Annual income

$54,003,807,702.14

Full VBIO calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — VBIO vs DIVO

📍 VBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VBIO	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VBIO + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VBIO pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBIO

Annual income on $10K today (after 15% tax)

$43,589.74/yr

After 10yr DRIP, annual income (after tax)

$45,903,236,546.82/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, VBIO beats the other by $45,903,235,712.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBIO + DIVO for your $10,000?

VBIO: 50%DIVO: 50%

100% DIVO50/50100% VBIO

Portfolio after 10yr

$37359.70M

Annual income

$27,001,904,341.91/yr

Blended yield

72.28%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBIO buys

DIVO buys

No recent congressional trades found for VBIO or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVBIODIVO

Forward yield	512.82% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$74719.37M ✓	$30.7K
Annual income after 10y	$54,003,807,702.14 ✓	$981.68
Total dividends collected	$72929.43M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: VBIO vs DIVO ($10,000, DRIP)

Year	VBIO Portfolio	VBIO Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$61,982	$51,282.05	$11,349	$649.42	+$50.6K → VBIO
2	$363,383	$297,062.31	$12,833	$688.83	+$350.6K → VBIO
3	$2,016,476	$1,627,655.79	$14,459	$727.90	+$2.00M → VBIO
4	$10,598,885	$8,441,255.59	$16,238	$766.49	+$10.58M → VBIO
5	$52,806,644	$41,465,837.52	$18,179	$804.47	+$52.79M → VBIO
6	$249,582,121	$193,079,012.24	$20,293	$841.71	+$249.56M → VBIO
7	$1,119,909,823	$852,856,952.70	$22,591	$878.14	+$1119.89M → VBIO
8	$4,774,834,551	$3,576,531,040.71	$25,087	$913.65	+$4774.81M → VBIO
9	$19,360,340,566	$14,251,267,596.86	$27,791	$948.18	+$19360.31M → VBIO
10	$74,719,372,108	$54,003,807,702.14	$30,718	$981.68	+$74719.34M → VBIO

VBIO vs DIVO: Complete Analysis 2026

VBIO — Stock

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.

Full VBIO Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this VBIO vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBIO vs SCHD VBIO vs JEPI VBIO vs O VBIO vs KO VBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.